ANIK News 39.23 Anika Therapeutics Inc (ANIK)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Anika Therapeutics Inc (ANIK) 39.23 $ANIK

Stocks Back Out Of Early Gains; SanDisk, Chipotle Rise
at Investor's Business Daily - Thu Apr 17, 9:32AM CDT
A long roster of earnings reports launched stocks higher, but gains quickly faded in heavy trade Thursday. The Nasdaq, S&P 500 and Dow Jones industrial average reversed early gains in the stock market today and were down 0.1% each. Volume surged at...

Anika Therapeutics Announces Date of First-Quarter 2014 Financial Results Conference Call
Business Wire - Wed Apr 16, 4:08PM CDT
Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it plans to issue its first-quarter 2014 financial results after the close of the market on Tuesday, April 29, 2014. The company plans to hold a conference call the next day, Wednesday, April 30 at 9:00 a.m. ET to discuss its financial results, business highlights and outlook. In addition, the company will answer questions concerning business and financial developments and trends, and other business and financial matters affecting the company, some of the responses to which may contain information that has not been previously disclosed.

Dow, S&P 500 Back In Plus Column
at Investor's Business Daily - Tue Apr 15, 1:56PM CDT
Stocks mounted a comeback and have turned mixed in late trading Tuesday. The Dow Jones industrial average and the S&P 500 were each up about 0.1%. They were off by as much as 0.7% and 0.8%, respectively. Meanwhile, the Nasdaq pared a 1.9% drop to...

Anika Therapeutics Announces First U.S. Commercial Sale of Monovisc(R)
Business Wire - Tue Apr 15, 1:30PM CDT
Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair, based on hyaluronic acid ("HA" technology, today announced the first U.S. commercial sale of Monovisc(R) by its commercial partner, DePuy Synthes Mitek Sports Medicine*, a leading orthopedic sports medicine company.

Nasdaq Nears 200-Day Line As Sell-Off Intensifies
at Investor's Business Daily - Tue Apr 15, 12:33PM CDT
Stocks vastly worsened Tuesday afternoon amid disappointing economic data and rising tensions between Russia and Ukraine. The Nasdaq plunged 1.8%, putting it closer to its 200-day moving average. The S&P 500 and the Dow Jones industrial average fell...

Shares of ANIK Up 6.9% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Apr 15, 11:18AM CDT
SmarTrend identified an Uptrend for Anika Therapeutics (NASDAQ:ANIK) on February 21st, 2014 at $34.68. In approximately 2 months, Anika Therapeutics has returned 6.88% as of today's recent price of $37.06.

Stocks Jump In Weak Trade
at Investor's Business Daily - Mon Apr 14, 9:30AM CDT
Stocks rebounded sharply Monday, as investors responded to healthy March retail sales data. The Nasdaq and S&P 500 bucked up 0.6% at the start of trade. The Dow Jones industrial average climbed 0.5%. The stock market today opened in weak trade, with...

Facebook, Spirit, Gentherm Rank At Top Of The IBD 50
at Investor's Business Daily - Sat Apr 12, 7:02AM CDT
The market is in correction, but investors can still find good stocks to keep an eye on by focusing on companies that display strong fundamentals. Gentherm (THRM), Spirit Airlines (SAVE), Facebook (FB), Anika Therapeutics (ANIK) and Manitowoc (MTW)...

Facebook, Arris, Grifols Initiate New Bases
at Investor's Business Daily - Fri Apr 11, 5:35PM CDT
With the stock market in a correction, the investor should emphasize defense. This means keeping cash in the portfolio, cutting losses on any stocks that are falling fast, and taking at least some profits on stocks that trigger key sell signals....

Biotech IPOs Adamas, Cerulean Slump In Trading Debut
at Investor's Business Daily - Thu Apr 10, 3:02PM CDT
Adamas Pharmaceuticals (ADMS) and Cerulean Pharma (CERU) launched IPOs Thursday, two of four biotechs expected to debut this week. Adamas priced at 16, the low end of its range. In late afternoon trading, the stock was near 15.30 on the stock market...

Software, Biotech, Solar Names Weigh on Nasdaq
at Investor's Business Daily - Thu Apr 10, 1:58PM CDT
Major averages fell sharply and were near session lows Thursday, as selling in growth stocks continued unabated. The Nasdaq gave up the most ground, falling 2.6% as software, biotech and solar stocks underperformed. The S&P 500 fell 1.5% and the Dow...

Sellers Dictate Action As Growth Stocks Tumble Again
at Investor's Business Daily - Thu Apr 10, 12:22PM CDT
Major averages tumbled again Thursday on no specific news, but institutional selling once again made its presence felt. The Nasdaq cratered 2.5% as software, biotech and solar stocks fell sharply. The S&P 500 lost 1.4% and the Dow Jones industrial...

Stocks Fall Hard In Early Trade; Biotechs Take Heat Again
at Investor's Business Daily - Thu Apr 10, 11:06AM CDT
Stocks fell sharply and were near session lows Thursday as the market correction gained a bit more steam. Biotechs faced another round of selling, resulting in another day of underperformance for the Nasdaq. The Nasdaq lost 1.8%; the S&P 500 gave up...

PolyOne, Anika, Methode Among The Leading Small Caps
at Investor's Business Daily - Thu Apr 10, 7:02AM CDT
The market is in correction but investors can still find stocks that are poised to post big gains during this earnings season. The season official kicked off Tuesday with Alcoa (AA) reporting late. Kapstone Paper & Packaging (KS), Anika Therapeutics...

Nasdaq Up 1.7%; Bed, Bath & Beyond Sinks After Hours
at Investor's Business Daily - Wed Apr 09, 4:13PM CDT
The major averages climbed more than 1% Wednesday, as more earnings reports came out after the closing bell. The Nasdaq led the way, climbing 1.7%. The Dow Jones industrial average and S&P 500 each rose 1.1%. But NYSE and Nasdaq volume was...

Stocks Extend Gains; Trimble Navigation Finds Support
at Investor's Business Daily - Wed Apr 09, 3:15PM CDT
Stocks strengthened and were near session highs Wednesday, after the minutes from the March 19 Fed meeting were released at 2 p.m. ET and revealed some dovishness among central bankers. With a little over one hour remaining in the session, the Nasdaq...

11.0% Return Seen to Date on SmarTrend Anika Therapeutics Call (ANIK)
Comtex SmarTrend(R) - Tue Apr 08, 9:58AM CDT
SmarTrend identified an Uptrend for Anika Therapeutics (NASDAQ:ANIK) on February 21st, 2014 at $34.68. In approximately 2 months, Anika Therapeutics has returned 11.02% as of today's recent price of $38.49.

Outsourcing Helps Anika Therapeutics Ramp Up Growth
at Investor's Business Daily - Fri Apr 04, 3:59PM CDT
In February, Anika Therapeutics won approval from U.S. regulators for a new osteoarthritis treatment. It didn't come easily. Charles Sherwood, Anika's president and chief executive, called the three-year process "a long and difficult road." The new...

Germany Orthobiologics Market Outlook to 2020
M2 - Mon Mar 31, 10:47AM CDT
Research and Markets (http://www.researchandmarkets.com/research/dmrzwh/germany) has announced the addition of the "Germany Orthobiologics Market Outlook to 2020" report to their offering. "Germany Orthobiologics Market Outlook to 2020", provides key market data on the Germany Orthobiologics market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Bone Graft Substitutes, Viscosupplementation, Bone Allografts and Bone Growth Stimulators. The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Orthobiologics market wherever available. Scope - Market size for Orthobiologics market categories - Bone Graft Substitutes, Viscosupplementation, Bone Allografts and Bone Growth Stimulators. - Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2005 to 2012 and forecast to 2020. - 2012 company shares and distribution shares data for each of the market categories. - Global corporate-level profiles of key companies operating within the Germany Orthobiologics market. Key players covered include: - Medtronic, Inc. - DePuy Companies - Biomet, Inc. - Stryker Corporation - Sanofi - Baxter International Inc. - DJO Finance LLC - Arthrex, Inc. - Ferring International Center S.A. - Wright Medical Group, Inc. - Seikagaku Corporation - Anika Therapeutics, Inc. - NuVasive, Inc. - curasan AG - Alphatec Holdings, Inc. - Globus Medical, Inc. For more information visit http://www.researchandmarkets.com/research/dmrzwh/germany
Scroll down for more posts ▼

Top 10 Most Recent News Articles

University of Phoenix Poll Gets a Useful Reality Check

Updated Category News Views 31

Good Numbers, With the Usual Fine Print Employer approval is the kind of evidence career-focused schools desperately need, and University of Phoenix just put up a pretty loud batch of it. Among managers who directly supervise its graduates, 94% said the university understands employer needs, while 92% said its programs align with workforce demands. Those are stout...

Continue Reading
PCS Rental Prep Is About Control Before Distance Hits

Updated Category News Views 82

A vacant house can turn into a long-distance headache with startling speed. For military homeowners preparing for a PCS move, the useful point in Rhonda Leahy's guidance is not glamorous: settle the boring operational stuff before the moving boxes, travel orders, and new-duty-station chaos swallow the calendar. Renting out a former home is not merely collecting enough...

Continue Reading
West Virginia SEO Timelines Demand Patience, Not Hype

Updated Category News Views 68

A fresh website with no search footprint is not a race car; it is a pickup stuck in mud, and Sean O'Kelly's view of local SEO in West Virginia puts that inconvenient fact right on the table. Most businesses can expect measurable improvement after three to six months of consistent work, according to the HelloNation article. That is not a glamorous answer, but it is the...

Continue Reading
1031 Specialists Takes Tax Deferral to Public TV

Updated Category News Views 100

A tax rule most people ignore is getting a television spotlight. 1031 Specialists says it will appear on All Access with Andy Garcia, an educational series distributed to Public Television stations nationwide, to explain the 1031 exchange and its role in real estate investing. That is a sensible bit of exposure for a niche business built around a topic investors tend to...

Continue Reading
California Initiative Puts Missed Diagnoses in Focus

Updated Category News Views 5

When Reassurance Turns Into a Risk A clean scan can become a dangerous lullaby when symptoms refuse to leave. That is the hard, unsettling territory behind Hodes Milman’s new Missed Diagnosis Project: California, launched November 20, 2026. The statewide effort focuses on breast cancer diagnostic failures: scans read as benign when more scrutiny was warranted, referrals...

Continue Reading
S&P Global's UBS AI Conference Slot Deserves Attention

Updated Category News Views 44

Thirty Minutes Can Still Matter A half-hour fireside chat is not a quarterly earnings call, and anybody treating it like one is setting themselves up for disappointment. Still, S&P Global CEO Martina Cheung appearing at the UBS Global Technology and AI Conference on December 2 deserves a spot on the calendar for owners of NYSE:SPGI. This is a company sitting in the middle...

Continue Reading
Surfcomber Uses Art Week to Deepen Its Guest Appeal

Updated Category News Views 70

Miami Art Week can turn every hotel lobby into a billboard, but Surfcomber is at least trying to make its walls do some actual work. Kimpton Surfcomber Hotel is spreading local artists, participatory events, food, cocktails and retail across the property rather than hanging a few paintings and calling it culture. For a South Beach hotel with 200 feet of oceanfront, that...

Continue Reading
Sivers Moves Q3 Release to Accommodate U.S. Investors

Updated Category News Views 74

Thanksgiving has a nasty habit of turning perfectly ordinary earnings dates into ghost towns, and Sivers Semiconductors has sensibly stepped around that pothole. The company will publish its third-quarter 2026 interim report on Monday, November 30, rather than Thursday, November 26. That is not a strategy reset, a warning, or some grand corporate mystery. It is a calendar...

Continue Reading
PPL's January Dividend Keeps Utility Appeal Intact

Updated Category News Views 103

A dividend notice is rarely thrilling, but it can still separate a steady utility from a story stock peddling fumes. PPL Corporation declared a quarterly common dividend of $0.2850 per share on Nov. 20, payable Jan. 4, 2027. Shareholders must be on the books by Dec. 10, 2026, to receive it. Plain vanilla stuff, yes. Still, plain vanilla is often precisely why utility...

Continue Reading
Africa Tech Festival Puts Trust Ahead of AI Hype Cycle

Updated Category News Views 75

Fifteen thousand people can fill a convention centre, but they cannot magically deliver a package, fund a small business, or repair harm from a bad automated decision. That rather useful dose of reality ran through the final day of Africa Tech Festival 2026 in Cape Town. The 29th edition drew more than 15,000 delegates across three days, and the strongest message was not...

Continue Reading

Top 5 Most Recently Viewed Articles

Long-Term Efficacy of FINTEPLA in Managing Lennox-Gastaut Syndrome

Updated Category News Views 124

Long-Term Efficacy of FINTEPLA in Managing Lennox-Gastaut Syndrome FINTEPLA, known scientifically as fenfluramine, has demonstrated remarkable potential in treating seizures associated with Lennox-Gastaut syndrome (LGS) as confirmed by a significant open-label extension (OLE) study. This study emphasized the drug's beneficial effects, particularly in lowering seizure...

Continue Reading
Implications of U.S. Withdrawal from the Paris Agreement

Updated Category News Views 370

Significance of the U.S. Withdrawal from the Paris Agreement The decision by the U.S. to withdraw from the Paris Agreement is a critical moment not just for America, but for the entire globe. Analysts and climate diplomats suggest that this move will have far-reaching consequences, more profound than those witnessed during the initial exit in recent years. Accelerating...

Continue Reading
Ambarella's Oculii AI Technology Enhances Lotus Electric Vehicles

Updated Category News Views 236

Ambarella's Oculii AI Radar Transforms Lotus Vehicles In a major technological breakthrough, Ambarella has announced the worldwide rollout of its Oculii™ AI 4D imaging radar technology in Lotus's 2023 and 2024 electric vehicles. This advanced technology is integrated into the eye-catching Lotus Eletre electric hyper-SUV and the thrilling Lotus Emeya hyper-GT models....

Continue Reading
Luxury Brands Adapt to Broader Market with Affordable Options

Updated Category News Views 355

Luxury Brands Embrace Affordability for Wider Appeal In recent times, luxury brands have found themselves in a challenging position. With diminishing demand for high-priced items like $3,000 handbags and $4,000 cashmere jackets, many luxury labels are shifting their focus. They are creating a wider array of products targeting the middle-class customer, including...

Continue Reading
Elife Group's Game-Changing Platform for Global Transport Solutions

Updated Category News Views 328

Elife Group Launches Revolutionary Multi-Modal Travel Platform Elife Group has introduced an innovative multi-modal platform that redefines ground transportation. By seamlessly integrating rail and ride-hailing services into a single platform, they have created a comprehensive solution for travelers seeking convenient and efficient options. This strategic move positions...

Continue Reading